Location History:
- Berlin, DE (2002 - 2009)
- Oranienburg, DE (2002 - 2021)
- Ely, GB (2018 - 2021)
Company Filing History:
13 out of 1,384 
5 out of 3,923 
3 out of 787 
Years Active: 2002-2021
Title: Andreas Menrad - Innovator in Immunotherapy
Introduction
Andreas Menrad, located in Oranienburg, Germany, is a distinguished inventor with a total of 23 patents to his name. His significant contributions to the field of immunotherapy highlight his dedication to advancing medical science through innovative solutions.
Latest Patents
Menrad's latest patents showcase his focus on monoclonal antibodies and their applications in immunosuppressive therapies. One of his prominent inventions includes an anti-αβTCR antibody, which comprises humanized monoclonal antibodies incorporating the CDRs of the murine antibody BMA031. This invention aims to enhance binding to the apTCR.CD3 complex and improve biological properties. Additionally, he has developed methods for optimizing immunosuppressive therapy through the multiple administrations of an αβTCR-binding polypeptide, which is derived from the same murine monoclonal antibody. These innovative methods further explore humanized monoclonal antibodies and their fragments to efficiently reduce αβ T cells in subjects, showcasing Menrad's commitment to providing advanced therapeutic solutions.
Career Highlights
Throughout his career, Andreas Menrad has contributed to leading pharmaceutical companies, including Schering Aktiengesellschaft and Novartis AG. His experience in these organizations has enabled him to collaborate on groundbreaking research and development projects, particularly in the realm of immunotherapy.
Collaborations
Menrad has worked closely with notable colleagues like Martin Haberey and Andreas Huth, who have played vital roles in advancing his innovations. Together, they have contributed to the development of novel therapeutic strategies that push the boundaries of modern medicine.
Conclusion
Andreas Menrad's innovative work in immunotherapy, backed by his impressive patent portfolio, positions him as a leading figure in the medical research community. His focus on the development of humanized monoclonal antibodies reflects the potential for significant advancements in treating autoimmune diseases and improving patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.